Athira Pharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Athira Pharma, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • Athira Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $99K, a 52.9% decline year-over-year.
  • Athira Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $493K, a 24.6% decline from 2022.
  • Athira Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $654K, a 99.3% decline from 2021.
  • Athira Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $97.1M, a 66.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $493K -$161K -24.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $654K -$96.4M -99.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $97.1M -$196M -66.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $293M +$292M +30846% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $946K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.